Omega 3 Fatty Acid Trial

NCT ID: NCT00586222 Phase: PHASE1 Status: COMPLETED Enrollment: 19 Completion: 2010-03

Conditions

Omega-3 Fatty Acids, Pediatric Bipolar Disorder, Adolescent Bipolar Disorder, Magnetic Resonance Spectroscopy Imaging

Interventions

Omega-3 Fatty Acid, Placebo

Summary

This study is being done to detect the metabolic changes that Omega 3 fatty acid treatment has on the brain and to find out whether magnetic resonance spectroscopy (MRS) scan can detect metabolic differences between bipolar patients and healthy control participants.

Primary Outcome

Cases will classify as either treatment responders or non. Using dichotomous assessment, logistic regression will assess association of regional mI levels and mood measures taken at baseline, adjusting for important covariates such as age and gender.

Source

ClinicalTrials.gov